311 related articles for article (PubMed ID: 25151356)
21. Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
Tishchenko I; Milioli HH; Riveros C; Moscato P
PLoS One; 2016; 11(6):e0158259. PubMed ID: 27341628
[TBL] [Abstract][Full Text] [Related]
22. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.
Harrell JC; Prat A; Parker JS; Fan C; He X; Carey L; Anders C; Ewend M; Perou CM
Breast Cancer Res Treat; 2012 Apr; 132(2):523-35. PubMed ID: 21671017
[TBL] [Abstract][Full Text] [Related]
23. Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control.
de Rinaldis E; Gazinska P; Mera A; Modrusan Z; Fedorowicz GM; Burford B; Gillett C; Marra P; Grigoriadis A; Dornan D; Holmberg L; Pinder S; Tutt A
BMC Genomics; 2013 Sep; 14():643. PubMed ID: 24059244
[TBL] [Abstract][Full Text] [Related]
24. Sense-antisense gene-pairs in breast cancer and associated pathological pathways.
Grinchuk OV; Motakis E; Yenamandra SP; Ow GS; Jenjaroenpun P; Tang Z; Yarmishyn AA; Ivshina AV; Kuznetsov VA
Oncotarget; 2015 Dec; 6(39):42197-221. PubMed ID: 26517092
[TBL] [Abstract][Full Text] [Related]
25. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
26. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
[TBL] [Abstract][Full Text] [Related]
27. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
28. Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Tanioka M; Fan C; Parker JS; Hoadley KA; Hu Z; Li Y; Hyslop TM; Pitcher BN; Soloway MG; Spears PA; Henry LN; Tolaney S; Dang CT; Krop IE; Harris LN; Berry DA; Mardis ER; Winer EP; Hudis CA; Carey LA; Perou CM
Clin Cancer Res; 2018 Nov; 24(21):5292-5304. PubMed ID: 30037817
[No Abstract] [Full Text] [Related]
29. Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
[TBL] [Abstract][Full Text] [Related]
30. Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer.
Kalyana-Sundaram S; Shankar S; Deroo S; Iyer MK; Palanisamy N; Chinnaiyan AM; Kumar-Sinha C
Neoplasia; 2012 Aug; 14(8):702-8. PubMed ID: 22952423
[TBL] [Abstract][Full Text] [Related]
31. Integrated profiling of basal and luminal breast cancers.
Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
[TBL] [Abstract][Full Text] [Related]
32. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
Valla M; Engstrøm MJ; Ytterhus B; Hansen ÅK; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
Breast Cancer Res Treat; 2017 Apr; 162(2):243-253. PubMed ID: 28124285
[TBL] [Abstract][Full Text] [Related]
33. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
34. Functional genomics to explore cancer cell vulnerabilities.
Kahle KT; Kozono D; Ng K; Hsieh G; Zinn PO; Nitta M; Chen CC
Neurosurg Focus; 2010 Jan; 28(1):E5. PubMed ID: 20043720
[TBL] [Abstract][Full Text] [Related]
35. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.
Chin SF; Teschendorff AE; Marioni JC; Wang Y; Barbosa-Morais NL; Thorne NP; Costa JL; Pinder SE; van de Wiel MA; Green AR; Ellis IO; Porter PL; Tavaré S; Brenton JD; Ylstra B; Caldas C
Genome Biol; 2007; 8(10):R215. PubMed ID: 17925008
[TBL] [Abstract][Full Text] [Related]
36. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
37. Linking signaling pathways to transcriptional programs in breast cancer.
Osmanbeyoglu HU; Pelossof R; Bromberg JF; Leslie CS
Genome Res; 2014 Nov; 24(11):1869-80. PubMed ID: 25183703
[TBL] [Abstract][Full Text] [Related]
38. An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.
Jiang Y; Liu L; Shan W; Yang ZQ
Mol Oncol; 2016 Feb; 10(2):292-302. PubMed ID: 26588862
[TBL] [Abstract][Full Text] [Related]
39. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
[TBL] [Abstract][Full Text] [Related]
40. Integrated genomics and functional validation identifies malignant cell specific dependencies in triple negative breast cancer.
Patel N; Weekes D; Drosopoulos K; Gazinska P; Noel E; Rashid M; Mirza H; Quist J; Brasó-Maristany F; Mathew S; Ferro R; Pereira AM; Prince C; Noor F; Francesch-Domenech E; Marlow R; de Rinaldis E; Grigoriadis A; Linardopoulos S; Marra P; Tutt ANJ
Nat Commun; 2018 Mar; 9(1):1044. PubMed ID: 29535384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
